Zoetis Inc (ZTS) Position Cut by Stack Financial Management Inc

Stack Financial Management Inc decreased its position in Zoetis Inc (NYSE:ZTS) by 1.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 340,582 shares of the company’s stock after selling 4,446 shares during the period. Zoetis makes up 2.5% of Stack Financial Management Inc’s holdings, making the stock its 11th biggest holding. Stack Financial Management Inc owned about 0.07% of Zoetis worth $24,536,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in ZTS. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Zoetis by 16.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after purchasing an additional 230 shares during the period. Steward Partners Investment Advisory LLC acquired a new position in shares of Zoetis during the third quarter valued at about $114,000. Harfst & Associates Inc. raised its holdings in shares of Zoetis by 16.1% during the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after purchasing an additional 260 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of Zoetis by 251.9% during the third quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after purchasing an additional 1,360 shares during the period. Finally, Shine Investment Advisory Services Inc. raised its holdings in shares of Zoetis by 86.5% during the third quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after purchasing an additional 1,040 shares during the period. Institutional investors and hedge funds own 93.14% of the company’s stock.

Shares of Zoetis Inc (NYSE ZTS) opened at $76.62 on Monday. The company has a debt-to-equity ratio of 2.45, a current ratio of 2.80 and a quick ratio of 1.95. Zoetis Inc has a fifty-two week low of $52.00 and a fifty-two week high of $77.03. The firm has a market cap of $37,340.00, a PE ratio of 40.33, a P/E/G ratio of 1.83 and a beta of 1.06.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.02. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the prior year, the business posted $0.52 EPS. The firm’s revenue was up 8.5% compared to the same quarter last year. analysts expect that Zoetis Inc will post 2.36 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be given a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.66%. This is an increase from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date is Thursday, January 18th. Zoetis’s dividend payout ratio is presently 26.32%.

Several equities analysts have recently weighed in on the stock. Piper Jaffray Companies reiterated a “buy” rating and set a $86.00 price objective on shares of Zoetis in a report on Thursday. BMO Capital Markets upped their price objective on shares of Zoetis from $65.00 to $70.00 and gave the company a “market perform” rating in a report on Friday, November 3rd. BidaskClub lowered shares of Zoetis from a “buy” rating to a “hold” rating in a report on Thursday, October 26th. Cantor Fitzgerald reiterated a “buy” rating and set a $75.00 price objective on shares of Zoetis in a report on Tuesday, September 26th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $65.00 price objective on shares of Zoetis in a report on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $73.72.

ILLEGAL ACTIVITY NOTICE: “Zoetis Inc (ZTS) Position Cut by Stack Financial Management Inc” was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://stocknewstimes.com/2018/01/22/zoetis-inc-zts-position-cut-by-stack-financial-management-inc.html.

Zoetis Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply